News
Meeting us at SLAS Europe 2018 in Brussels!
Meeting us at SLAS Europe 2018, on Wednesday 27th & Thursday 28th of June on Molecular Device Booth (#401) at the Square Brussels Meeting Centre, Brussels, Belgium.
Our news
Notre actualité
News
Our last experience in ELRIG Fr and EUROoC meetings!
We had the pleasure to attend ELRIG Fr meeting in Bischoffsheim (near Strasbourg) on the 23-24th of May. There we enjoyed meeting our partners Molecular Devices and Integra biosciences, and seeing great presentations about the last trends in automation. Our collaborator Karim Si-Tayeb presented his amazing results regarding the differentiation Read more…
News
Discover our new application note made with Integra Biosciences about HCS and 3d cell culture
Thank to our partner Integra Biosciences, we are happy to present you an application note about a straightforward workflow for 3D cell seeding and spheroid formation using HCS Pharma’s BIOMIMESYS® plates in combination with INTEGRA’s VIAFLO 96/384 pipetting system and without forgetting to mention with the use of our imageXpress micro confocal Read more…
News
The GDPR is coming … and it’s important for your data!
As you should know, the GDPR (General Data Protection Regulation) is now a reality and every companies in Europe has to be “compliant” with it. Of course we’re updating our privacy policy (soon) but, in HCS Pharma, the respect of your data is at the heart of communication! We use it fairly, Read more…
News
Feedback from COSMED Event : new norms and new expectations in cosmetics
Last week, we attended to the 6th edition of COSMED Meeting in the west of France. We would like to thank the organisation team of COSMED for giving us the opportunity to attend to this event. During this day we have visited the new facilities of Technature, a famous french cosmetic manufacturer Read more…
News
Our new poster on BIOMIMESYS® Hydroscaffold is about automation of the processes
Our new poster on BIOMIMESYS® technology is now avalaible on this link. It presents the use of this scaffold on our automated platform (Hapix), with the development of a 3D cell model for steatosis and phospholipidosis assessment as an example. Automated HepG2 cells seeding, medium renewal, spheroids treatment, fixation, staining and Read more…
News
EUROcC (Organ-on-chip) conference in Stuttgart!
The first EUROoC meeting, dealing with organ-on-chip research and organized by the Chemical and Biological Microsystems Society (CBMS), will take place on the 24th-25th of May 2018 in Stuttgart (Germany). Interestingly, this new workshop will address the engineering challenges related to the design, fabrication and implementation of organ-on-chips (OOC) and microphysiological systems. Among other Read more…
News
Farah joins us to explore the agri-food market
Farah has joined us for a four-month internship to explore the sector of agri-food market in the north of France. After a bachelor degree in cellular biology and physiology with a specialization in nutrition, Farah is currently at the University of management and health sciences in Lille to acquire a Read more…
News
HCS pharma in ELRIGfr Strasbourg!
Next week (the 23th and the 24th of May), we will be in Strasbourg to participate to ELRIGfr event, where we will present two posters. The first poster is about BIOMIMESYS® hydroscaffold for 3D cell culture and the compatibility with automation; the plates can be seeded, treated easily using the VIAFLO 96/384. Read more…
News
Feedback on In Cosmetics 2018 : on the road to cosmetology sustainability!
Thanks a lot to the organization of In Cosmetics for this amazing event. In Cosmetics offered us a large diversity of matches including scientist and sales but also with our current partners. This year more than 9000 attendees were present and almost 1000 exhibitors from all over the world! Thanks Read more…
HCS, HCA & Biology
Induced pluripotent stem cells (iPSCs) to improve early detection of drug neurotoxicity
One third of the safety failures is linked to CNS toxicity during the clinical trials of drugs. In order to develop a more predictable in vitro human model for neurotoxicity testing, we have compared the sensibility of iPSC-derived neuronal cells and SH-SY5Y cell line (neuroblastoma-derived cell line) to a panel Read more…
News
First days at In Cosmetics Amsterdam!
We are very happy to be present at In Cosmetics Amsterdam ! We are here to talk about our news services for in vitro testing in cosmetics. We also bring with us some BIOMIMESYS® samples, so if you want to see our innovative 3D cell culture system. Don’t hesitate to contact Read more…
News
Meet us at In Cosmetics Amsterdam and discover our services in Dermocosmetology
Next week, we will be attending to In Cosmetics Global in Amsterdam from the 17th April to the 19th April 2018 In this event we will let you discover our lab in virtual reality and allow you to discover a large panel of In Vitro and Cellular Imaging services dedicated Read more…
News
Predicting clinical outcomes of wound healing assessment : the limitations of the mice model
Wounds can exhibit impaired healing, as a consequence of pathologic failure to process one of the normal stage of healing. Wound healing impairment could be characteristic of the treatments of chronic wounds due to immobilisation, diabetes, and skin infection. Characterization of compounds efficacy on wound healing parameters is important dermato Read more…
News
Venez échanger aux JNLF de Bordeaux avec notre CEO
Nathalie MAUBON, notre CEO/CSO, sera présente aux Journées de Neurologie de Langue Française qui se déroulent cette semaine à Bordeaux. Ce congrès regroupe neurologues, cliniciens, industriels qui font la promotion et le développement de la neurologie, en France et dans les pays francophones. Nathalie va présenter jeudi après-midi “Le criblage phénotypique comme nouveau Read more…
News
Is our new website more practical for you ?
As you can see, we have changed the design of this website. Thanks to advices of some customers and partners, we have choosen to more simple layout to emphasize our services and the news. We hope that you be pleased with this new website. Of course, don’t hesite to send Read more…
News
Europe is celebrating the fifth year without cosmeting testing on animals
Originally, cosmetics were tested on animals, but since a couple of year’s manufacturer have tried to avoid this test to match the new regulation on animal testing. Today, most of the test will be conducted on human skin or eye tissue or even human skin culture. In order to find Read more…
News
Feedback on Forum Labo Lyon 2018
Thanks a lot to Integra biosciences‘ and Molecular Devices‘ teams to have welcomed us on their respective booths at Forum Labo Lyon! It was a great pleasure to take part in this event by their side, as a proof of our fruitful – and hopefully long lasting – collaboration ! Read more…
News
Could the microbiota be the solution to all our health problem?
Microbiota is the community of the symbiotic and pathogenic microorganism that we would find in our intestine or on our skin. Today there is more and more researcher in Pharma or Dermocosmetology who are working on microbiota to find solution to treat different disease link to the inflammation and auto Read more…
News
Spring is coming and it’s time to change (our website!)
Yes, obviously we have missed the date of the beginning of Spring (21th of march) but not so much 🙂 We are very happy to show our new website for HCS Pharma and, the brand new BIOMIMESYS® site. For this special occasion, we invite you to visit our laboratory in Read more…
News
Join us at Forum Labo Lyon and discover our services with BIOMIMESYS®
Next week, we will be in the beautiful city of Lyon to participate to Forum Labo with our partners Molecular Devices and INTEGRA Biosciences. In this event we will present our brand new BIOMIMESYS® technology for 3D cell culture on INTEGRA Biosciences’s booth (#B18). This is an unique and natural Read more…
News
Feedback on SCMC meeting last week in Paris
The annual congress of the SCMC (French Brain and Cerebrovascular Diseases Society) took place in Paris last week. The meeting began with a mini-symposium entitled “Nanoparticles and the brain”, during which the therapeutic potential of nanomedicine was addressed: three invited speakers discussed the use of nanoparticules to treat cancers (by Read more…
News
Digital workspace and the use of immersive technologies: we share our experiments!
Last friday, our CDO talked at IT for Business meeting about the digital workspace and the use of immersive technologies in the evolution of work. It was a pleasure to share our experiences with famous companies like e.sncf, Axa France, Bouygues Telecom Entreprises or Forrester Research! Even if we are Read more…